Britton P, Duffy S W, Sinnatamby R, Wallis M G, Barter S, Gaskarth M, O'Neill A, Caldas C, Brenton J D, Forouhi P, Wishart G C
Department of Radiology, Cambridge Breast Unit, Box 97, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK.
Br J Cancer. 2009 Jun 16;100(12):1873-8. doi: 10.1038/sj.bjc.6605082. Epub 2009 May 19.
The aim of this study was to estimate the number of patients discharged from a symptomatic breast clinic who subsequently develop breast cancer and to determine how many of these cancers had been 'missed' at initial assessment. Over a 3-year period, 7004 patients were discharged with a nonmalignant diagnosis. Twenty-nine patients were subsequently diagnosed with breast cancer over the next 36 months. This equates to a symptomatic 'interval' cancer rate of 4.1 per 1000 women in the 36 months after initial assessment (0.9 per 1000 women within 12 months, 2.6 per 1000 women within 24 months). The lowest sensitivity of initial assessment was seen in patients of 40-49 years of age, and these patients present the greatest imaging and diagnostic challenge. Following multidisciplinary review, a consensus was reached on whether a cancer had been missed or not. No delay occurred in 10 patients (35%) and probably no delay in 7 patients (24%). Possible delay occurred in three patients (10%) and definite delay in diagnosis (i.e., a 'missed' cancer) occurred in only nine patients (31%). The overall diagnostic accuracy of 'triple' assessment is 99.6% and the 'missed' cancer rate is 1.7 per 1000 women discharged.
本研究的目的是估算从有症状乳腺门诊出院后随后发生乳腺癌的患者数量,并确定这些癌症中有多少在初次评估时被“漏诊”。在3年期间,7004例患者以非恶性诊断出院。在接下来的36个月里,有29例患者随后被诊断为乳腺癌。这相当于初次评估后36个月内有症状的“间隔”癌症发生率为每1000名女性4.1例(12个月内每1000名女性0.9例,24个月内每1000名女性2.6例)。初次评估的最低敏感性见于40 - 49岁的患者,这些患者带来了最大的影像学和诊断挑战。经过多学科评估后,就癌症是否被漏诊达成了共识。10例患者(35%)没有延误,7例患者(24%)可能没有延误。3例患者(10%)可能有延误,只有9例患者(31%)出现了明确的诊断延误(即“漏诊”癌症)。“三联”评估的总体诊断准确率为99.6%,每1000名出院女性的“漏诊”癌症发生率为1.7例。